sur VALBIOTIS (EPA:ALVAL)
Valbiotis to Launch Valbiotis®PRO Metabolic Health in February
Valbiotis, a French research laboratory, will introduce Valbiotis®PRO Metabolic Health on February 3rd in France. This dietary supplement, created from the patented active ingredient TOTUM•63, offers a plant-based solution to manage moderate dysglycemia and other metabolic syndrome parameters without drugs. The product aims at addressing rising concerns around metabolic diseases, notably type 2 diabetes.
Validated through four clinical trials, TOTUM•63 is recognized in 58 countries. The French launch involves a multi-channel marketing effort akin to Valbiotis®PRO Cholesterol. The product will be available nationwide in pharmacies and online, priced at €22.95 for 90 capsules and €39.95 for 180 capsules.
The launch confirms Valbiotis' commercial commitment, with further product releases scheduled for 2025. Valbiotis specializes in scientifically-backed nutritional supplements that promote health and prevent disease.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de VALBIOTIS